Middle East And Africa Hearing Aids Market
Market Size in USD Million
CAGR :
%
USD
750.30 Million
USD
1,399.07 Million
2022
2030
| 2023 –2030 | |
| USD 750.30 Million | |
| USD 1,399.07 Million | |
|
|
|
Middle East and Africa Hearing Aids Market, By Product (Hearing Aid Devices, Hearing Implants), Device type (Digital Hearing Aids, Analog Hearing Aids), Type of Hearing Loss (Sensorineural Hearing Loss, Conductive Hearing Loss), Patient Type (Adults, Pediatrics), Distribution Channel (Large Retail Chains, Manufacturer Owned Retail Chains, Public, Others) - Industry Trends and Forecast to 2030.
Middle East and Africa Hearing Aids Market Analysis and Size
The Middle East and Africa region has a high prevalence of hearing loss, primarily due to factors such as age-related hearing loss, noise-induced hearing loss, and genetic factors. The aging population, exposure to high noise levels, and increased awareness about hearing health have contributed to a rise in the number of individuals seeking hearing aids.
Data Bridge Market Research analyses that the Middle East and Africa hearing aids market which was USD 750.30 Million in 2022, is expected to reach USD 1,399.07 Million by 2030, and is expected to undergo a CAGR of 8.1% during the forecast period. This indicates the market value. “Hearing Aid Devices” dominates product segment of the Middle East and Africa hearing aids market owing to the increasing investment in healthcare. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Middle East and Africa Hearing Aids Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015-2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Product (Hearing Aid Devices, Hearing Implants), Device type (Digital Hearing Aids, Analog Hearing Aids), Type of Hearing Loss (Sensorineural Hearing Loss, Conductive Hearing Loss), Patient Type (Adults, Pediatrics), Distribution Channel (Large Retail Chains, Manufacturer Owned Retail Chains, Public, Others) |
|
Countries Covered |
Saudi Arabia, South Africa, U.A.E., Israel, Kuwait, Egypt and Rest of Middle East and Africa |
|
Market Players Covered |
WIDEX A/S (Denmark), GN Store Nord A/S (Denmark), Sonova (Switzerland), Sivantos Pte. Ltd (Singapore), Microson (Spain), Horentek (Turkey), RION CO. Ltd (Japan), William Demant Holding A/S (Denmark), Amplifon, Starkey (Italy), MED-EL Medical Electronics (Austria), Cochlear Ltd.(Australia), SeboTek Hearing Systems, LLC. (U.S.), Audina Hearing Instruments, Inc. (U.S.), Arphi Electronics Private Limited (India), and Zounds Hearing (U.S.) |
|
Market Opportunities |
|
Market Definition
The hearing aids market is the industry involved in the manufacturing, distribution, and sales of devices designed to assist individuals with hearing loss. Hearing aids are electronic devices that amplify sound for individuals with varying degrees of hearing impairment. They are typically worn in or behind the ear and help enhance the perception of sound by amplifying and processing incoming sounds.
Middle East and Africa Hearing Aids Market Dynamics
Drivers
- Increasing Prevalence of Hearing Loss
Hearing loss is not limited to the elderly. Factors such as exposure to noise, genetic predisposition, and certain medical conditions contribute to hearing loss across different age groups. The increasing prevalence of hearing loss, both in older adults and younger populations, fuels the demand for hearing aids
- Government Initiatives and Policies
Governments and regulatory bodies have implemented initiatives to address hearing loss and improve access to hearing healthcare. These include mandates for hearing screenings, public health programs, subsidies, and insurance coverage for hearing aids. Supportive government policies drive market growth by making hearing aids more accessible and affordable
Opportunity
- Technological Advancements
The rapid pace of technological advancements presents opportunities for further innovation in the hearing aids market. Advancements such as artificial intelligence, machine learning, and digital health integration can enhance the functionality and performance of hearing aids, improving user experience and outcomes
Furthermore, the rising collaboration, merger, and acquisition among the market players will extend profitable opportunities for the market players in the forecast period from 2023 to 2030. In addition, rising number of market players will further expand the market's growth rate in the future
Restraints/Challenges
- Limited Access to Hearing Healthcare
Access to qualified audiologists and hearing healthcare professionals is limited in certain regions, particularly in rural or underserved areas. The lack of availability of professionals for proper diagnosis, fitting, and ongoing support restricts the uptake and use of hearing aids, leading to a gap in hearing healthcare
On the other hand, the high cost associated with the product manufacturing is expected to obstruct market growth. Also, the disruption in the supply chain industry has the potential to challenge the market’s growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, and lack of suitable infrastructure are projected to challenge the market in the forecast period from 2023 to 2030
This Middle East and Africa hearing aids market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Middle East and Africa hearing aids market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth
Recent Developments
- In 2019, Sonova introduced the Phonak Marvel 2.0, an upgraded version of the Marvel platform with enhanced features such as improved sound quality and extended Bluetooth connectivity options
- In 2018, Sonova launched the Phonak Marvel hearing aids, which introduced direct streaming capabilities for phone calls, music, and other audio content from smartphones and other Bluetooth-enabled devices
Middle East and Africa Hearing Aids Market Scope
The Middle East and Africa hearing aids market is segmented on the basis of product, device type, type of hearing loss, patient type, and distribution channel. The growth amongst these segments will help you analyse meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Hearing Aid Devices
- Hearing Implants
Device Type
- Digital Hearing Aids
- Analog Hearing Aid
Type of Hearing Loss
- Sensorineural Hearing Loss
- Conductive Hearing Loss
Patient Type
- Adults
- Pediatrics
Distribution Channel
- Large Retail Chains
- Manufacturer Owned Retail Chains
- Public
- Others
Middle East and Africa hearing aids market Regional Analysis/Insights
Middle East and Africa hearing aids market is analyzed, and market size insights and trends are provided by product, device type, type of hearing loss, patient type, and distribution channel as referenced above.
The countries covered in the Middle East and Africa hearing aids market report are Saudi Arabia, South Africa, U.A.E., Israel, Kuwait, Egypt and Rest of Middle East and Africa.
Saudi Arabia dominates the market due to factors including rising healthcare costs, increased R&D and trending technological advancements.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The hearing aids market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for hearing aids market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the hearing aids market. The data is available for historic period from 2015 to 2021.
Competitive Landscape and Hearing Aids Market Share Analysis
The hearing aids market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company’s focus related to hearing aids market.
Some of the major players operating in the hearing aids market are
- WIDEX A/S (Denmark)
- GN Store Nord A/S (Denmark)
- Sonova (Switzerland)
- Sivantos Pte. Ltd (Singapore)
- Microson (Spain)
- Horentek (Turkey)
- RION CO. Ltd (Japan)
- William Demant Holding A/S (Denmark)
- Amplifon Starkey (Italy)
- MED-EL Medical Electronics (Austria)
- Cochlear Ltd.(Australia)
- SeboTek Hearing Systems, LLC. (U.S.)
- Audina Hearing Instruments, Inc.(U.S.)
- Arphi Electronics Private Limited (India)
- Zounds Hearing (U.S.)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA HEARING AIDS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE EUROPE HEARING AIDS SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 MIDDLE EAST AND AFRICA HEARING AIDS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8 COST ANALYSIS BREAKDOWN
9 TECHNONLOGY ROADMAP
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11 REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12 REIMBURSEMENT FRAMEWORK
13 OPPUTUNITY MAP ANALYSIS
14 VALUE CHAIN ANALYSIS
15 HEALTHCARE ECONOMY
15.1 HEALTHCARE EXPENDITURE
15.2 CAPITAL EXPENDITURE
15.3 CAPEX TRENDS
15.4 CAPEX ALLOCATION
15.5 FUNDING SOURCES
15.6 INDUSTRY BENCHMARKS
15.7 GDP RATION IN OVERALL GDP
15.8 HEALTHCARE SYSTEM STRUCTURE
15.9 GOVERNMENT POLICIES
15.1 ECONOMIC DEVELOPMENT
16 MIDDLE EAST AND AFRICA HEARING AIDS MARKET, BY TECHNOLOGY
16.1 OVERVIEW
16.2 DIGITAL HEARING AIDS
16.3 CONVENTIONAL HEARING AIDS
17 MIDDLE EAST AND AFRICA HEARING AIDS MARKET, BY PRODUCT TYPE
17.1 OVERVIEW
17.2 HEARING AID DEVICES
17.2.1 RECEIVER-IN-THE-EAR HEARING AIDS
17.2.1.1. MICRO RIC/RITE
17.2.1.1.1. RECHARGABLE
17.2.1.1.1.1 MARKET VALUE (USD MN)
17.2.1.1.1.2 MARKET VOLUME (UNITS)
17.2.1.1.1.3 AVERAGE SELLINF PRICE (USD)
17.2.1.1.2. NON-RECHARGABLE
17.2.1.1.2.1 MARKET VALUE (USD MN)
17.2.1.1.2.2 MARKET VOLUME (UNITS)
17.2.1.1.2.3 AVERAGE SELLINF PRICE (USD)
17.2.1.2. STANDARD RIC/RITE
17.2.1.2.1. RECHARGABLE
17.2.1.2.1.1 MARKET VALUE (USD MN)
17.2.1.2.1.2 MARKET VOLUME (UNITS)
17.2.1.2.1.3 AVERAGE SELLINF PRICE (USD)
17.2.1.2.2. NON-RECHARGABLE
17.2.1.2.2.1 MARKET VALUE (USD MN)
17.2.1.2.2.2 MARKET VOLUME (UNITS)
17.2.1.2.2.3 AVERAGE SELLINF PRICE (USD)
17.2.2 BEHIND-THE-EAR HEARING AIDS
17.2.2.1. MINI BEHIND-THE EAR (BTE)
17.2.2.1.1. RECHARGABLE
17.2.2.1.1.1 MARKET VALUE (USD MN)
17.2.2.1.1.2 MARKET VOLUME (UNITS)
17.2.2.1.1.3 AVERAGE SELLINF PRICE (USD)
17.2.2.1.2. NON-RECHARGABLE
17.2.2.1.2.1 MARKET VALUE (USD MN)
17.2.2.1.2.2 MARKET VOLUME (UNITS)
17.2.2.1.2.3 AVERAGE SELLINF PRICE (USD)
17.2.2.2. STANDARD BEHIND-THE EAR (BTE)
17.2.2.2.1. RECHARGABLE
17.2.2.2.1.1 MARKET VALUE (USD MN)
17.2.2.2.1.2 MARKET VOLUME (UNITS)
17.2.2.2.1.3 AVERAGE SELLINF PRICE (USD)
17.2.2.2.2. NON-RECHARGABLE
17.2.2.2.2.1 MARKET VALUE (USD MN)
17.2.2.2.2.2 MARKET VOLUME (UNITS)
17.2.2.2.2.3 AVERAGE SELLINF PRICE (USD)
17.2.2.3. POWER BEHIND-THE EAR (BTE)
17.2.2.3.1. RECHARGABLE
17.2.2.3.1.1 MARKET VALUE (USD MN)
17.2.2.3.1.2 MARKET VOLUME (UNITS)
17.2.2.3.1.3 AVERAGE SELLINF PRICE (USD)
17.2.2.3.2. NON-RECHARGABLE
17.2.2.3.2.1 MARKET VALUE (USD MN)
17.2.2.3.2.2 MARKET VOLUME (UNITS)
17.2.2.3.2.3 AVERAGE SELLINF PRICE (USD)
17.2.2.4. SINGLE-SIDED HEARING
17.2.2.4.1. RECHARGABLE
17.2.2.4.1.1 MARKET VALUE (USD MN)
17.2.2.4.1.2 MARKET VOLUME (UNITS)
17.2.2.4.1.3 AVERAGE SELLINF PRICE (USD)
17.2.2.4.2. NON-RECHARGABLE
17.2.2.4.2.1 MARKET VALUE (USD MN)
17.2.2.4.2.2 MARKET VOLUME (UNITS)
17.2.2.4.2.3 AVERAGE SELLINF PRICE (USD)
17.2.3 IN-THE-EAR HEARING AIDS
17.2.3.1. INVISIBLE-IN-THE CANAL (IIC)
17.2.3.1.1. RECHARGABLE
17.2.3.1.1.1 MARKET VALUE (USD MN)
17.2.3.1.1.2 MARKET VOLUME (UNITS)
17.2.3.1.1.3 AVERAGE SELLINF PRICE (USD)
17.2.3.1.2. NON-RECHARGABLE
17.2.3.1.2.1 MARKET VALUE (USD MN)
17.2.3.1.2.2 MARKET VOLUME (UNITS)
17.2.3.1.2.3 AVERAGE SELLINF PRICE (USD)
17.2.3.2. COMPLETELY-IN-THE CANAL (CIC)
17.2.3.2.1. RECHARGABLE
17.2.3.2.1.1 MARKET VALUE (USD MN)
17.2.3.2.1.2 MARKET VOLUME (UNITS)
17.2.3.2.1.3 AVERAGE SELLINF PRICE (USD)
17.2.3.2.2. NON-RECHARGABLE
17.2.3.2.2.1 MARKET VALUE (USD MN)
17.2.3.2.2.2 MARKET VOLUME (UNITS)
17.2.3.2.2.3 AVERAGE SELLINF PRICE (USD)
17.2.3.3. IN-THE CANAL (ITC)
17.2.3.3.1. RECHARGABLE
17.2.3.3.1.1 MARKET VALUE (USD MN)
17.2.3.3.1.2 MARKET VOLUME (UNITS)
17.2.3.3.1.3 AVERAGE SELLINF PRICE (USD)
17.2.3.3.2. NON-RECHARGABLE
17.2.3.3.2.1 MARKET VALUE (USD MN)
17.2.3.3.2.2 MARKET VOLUME (UNITS)
17.2.3.3.2.3 AVERAGE SELLINF PRICE (USD)
17.2.3.4. MINI-CANAL (MC) HEARING AIDS
17.2.3.4.1. RECHARGABLE
17.2.3.4.1.1 MARKET VALUE (USD MN)
17.2.3.4.1.2 MARKET VOLUME (UNITS)
17.2.3.4.1.3 AVERAGE SELLINF PRICE (USD)
17.2.3.4.2. NON-RECHARGABLE
17.2.3.4.2.1 MARKET VALUE (USD MN)
17.2.3.4.2.2 MARKET VOLUME (UNITS)
17.2.3.4.2.3 AVERAGE SELLINF PRICE (USD)
17.2.3.5. MICROPHONE-IN-HELIX (MIH) HEARING AIDS
17.2.3.5.1. RECHARGABLE
17.2.3.5.1.1 MARKET VALUE (USD MN)
17.2.3.5.1.2 MARKET VOLUME (UNITS)
17.2.3.5.1.3 AVERAGE SELLINF PRICE (USD)
17.2.3.5.2. NON-RECHARGABLE
17.2.3.5.2.1 MARKET VALUE (USD MN)
17.2.3.5.2.2 MARKET VOLUME (UNITS)
17.2.3.5.2.3 AVERAGE SELLINF PRICE (USD)
17.2.4 OTHER HEARING AID DEVICES
17.3 HEARING IMPLANTS
17.3.1 COCHLEAR IMPLANTS
17.3.1.1. BY PROCESSOR
17.3.1.1.1. BEHIND THE EAR PROCESSOR
17.3.1.1.1.1 MARKET VALUE (USD MN)
17.3.1.1.1.2 MARKET VOLUME (UNITS)
17.3.1.1.1.3 AVERAGE SELLINF PRICE (USD)
17.3.1.1.2. BODY WORN PROCESSOR
17.3.1.1.2.1 MARKET VALUE (USD MN)
17.3.1.1.2.2 MARKET VOLUME (UNITS)
17.3.1.1.2.3 AVERAGE SELLINF PRICE (USD)
17.3.1.2. BY TYPE
17.3.1.2.1. ABUTEMENT
17.3.1.2.2. MAGNET
17.3.1.2.3. HEADBAND
17.3.1.3. BY PPS RATE
17.3.1.3.1. 32000 PPS
17.3.1.3.2. 51000 PPS
17.3.1.3.3. 82000 PPS
17.3.1.4. BY BATTERY
17.3.1.4.1. RECHARGEABLE
17.3.1.4.2. NON RECHARGEABLE
17.3.2 BONE CONDUCTION DEVICES
17.3.2.1. BY PROCESSOR
17.3.2.1.1. BEHIND THE EAR PROCESSOR
17.3.2.1.1.1 MARKET VALUE (USD MN)
17.3.2.1.1.2 MARKET VOLUME (UNITS)
17.3.2.1.1.3 AVERAGE SELLINF PRICE (USD)
17.3.2.1.2. BODY WORN PROCESSOR
17.3.2.1.2.1 MARKET VALUE (USD MN)
17.3.2.1.2.2 MARKET VOLUME (UNITS)
17.3.2.1.2.3 AVERAGE SELLINF PRICE (USD)
17.3.2.2. BY TYPE
17.3.2.2.1. ABUTEMENT (PERCUTANEOUS)
17.3.2.2.2. HEADBANDS
17.3.2.2.3. MAGNETS (TRANSCUTANEOUS)
17.3.2.3. BY BATTERY
17.3.2.3.1. RECHARGEABLE
17.3.2.3.2. NON RECHARGEABLE
17.3.3 MIDDLE EAR IMPLANTS
17.3.3.1. BY PROCESSOR
17.3.3.1.1. BEHIND THE EAR PROCESSOR
17.3.3.1.1.1 MARKET VALUE (USD MN)
17.3.3.1.1.2 MARKET VOLUME (UNITS)
17.3.3.1.1.3 AVERAGE SELLINF PRICE (USD)
17.3.3.1.2. BODY WORN PROCESSOR
17.3.3.1.2.1 MARKET VALUE (USD MN)
17.3.3.1.2.2 MARKET VOLUME (UNITS)
17.3.3.1.2.3 AVERAGE SELLINF PRICE (USD)
17.3.3.2. BY TRANSDUCERS
17.3.3.2.1. PIEZOELECTRIC
17.3.3.2.2. ELECTROMAGNETIC
17.3.4 AUDITORY BRAIN STEM IMPLANTS
17.3.4.1. BY PROCESSOR
17.3.4.1.1. BEHIND THE EAR PROCESSOR
17.3.4.1.1.1 MARKET VALUE (USD MN)
17.3.4.1.1.2 MARKET VOLUME (UNITS)
17.3.4.1.1.3 AVERAGE SELLINF PRICE (USD)
17.3.4.1.2. BODY WORN PROCESSOR
17.3.4.1.2.1 MARKET VALUE (USD MN)
17.3.4.1.2.2 MARKET VOLUME (UNITS)
17.3.4.1.2.3 AVERAGE SELLINF PRICE (USD)
17.3.4.2. BY ABI CHANNEL
17.3.4.2.1. SINGLE CHANNEL ABI SYSTEM
17.3.4.2.2. MULTI CHANNEL ABI SYSTEM
17.4 HEARING AID ACCESSORIES
17.4.1 HEARING AID BATTERIES
17.4.1.1. MARKET VALUE (USD MN)
17.4.1.2. MARKET VOLUME (UNITS)
17.4.1.3. AVERAGE SELLINF PRICE (USD)
17.4.2 WIRELESS ACCESSORIES
17.4.2.1. MICROPHONE
17.4.2.1.1. MARKET VALUE (USD MN)
17.4.2.1.2. MARKET VOLUME (UNITS)
17.4.2.1.3. AVERAGE SELLINF PRICE (USD)
17.4.2.2. RECEIVER
17.4.2.2.1. MARKET VALUE (USD MN)
17.4.2.2.2. MARKET VOLUME (UNITS)
17.4.2.2.3. AVERAGE SELLINF PRICE (USD)
17.4.2.3. REMOTE
17.4.2.3.1. MINI REMOTE MICROPHONE
17.4.2.3.1.1 MARKET VALUE (USD MN)
17.4.2.3.1.2 MARKET VOLUME (UNITS)
17.4.2.3.1.3 AVERAGE SELLINF PRICE (USD)
17.4.2.3.2. STANDARD REMOTE MICROPHONE
17.4.2.3.2.1 MARKET VALUE (USD MN)
17.4.2.3.2.2 MARKET VOLUME (UNITS)
17.4.2.3.2.3 AVERAGE SELLINF PRICE (USD)
17.4.3 HEARING PROTECTION
17.4.3.1. MARKET VALUE (USD MN)
17.4.3.2. MARKET VOLUME (UNITS)
17.4.3.3. AVERAGE SELLINF PRICE (USD)
17.4.4 WAX GUARD FILTERS
17.4.4.1. MARKET VALUE (USD MN)
17.4.4.2. MARKET VOLUME (UNITS)
17.4.4.3. AVERAGE SELLINF PRICE (USD)
17.4.5 OTHERS
18 MIDDLE EAST AND AFRICA HEARING AIDS MARKET, BY HEARING LOSS TYPE
18.1 OVERVIEW
18.2 SENSORINEURAL HEARING LOSS
18.2.1 HEARING AID DEVICES
18.2.2 HEARING IMPLANTS
18.2.3 HEARING AID ACCESSORIES
18.3 CONDUCTIVE HEARING LOSS
18.3.1 HEARING AID DEVICES
18.3.2 HEARING IMPLANTS
18.3.3 HEARING AID ACCESSORIES
18.4 MIXED HEARING LOSS
18.4.1 HEARING AID DEVICES
18.4.2 HEARING IMPLANTS
18.4.3 HEARING AID ACCESSORIES
18.5 OTHERS
19 MIDDLE EAST AND AFRICA HEARING AIDS MARKET, BY PATIENT TYPE
19.1 OVERVIEW
19.2 PEDIATRICS
19.3 ADULTS
19.4 GERIATRIC
20 MIDDLE EAST AND AFRICA HEARING AIDS MARKET, BY END USER
20.1 OVERVIEW
20.2 HOSPITALS
20.2.1 PUBLIC
20.2.2 PRIVATE
20.3 SPECIALTY CLINICS
20.4 HOME CARE SETTINGS
20.5 ENT CARE CENTRES
20.6 OTHERS
21 MIDDLE EAST AND AFRICA HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL
21.1 OVERVIEW
21.2 DIRECT TENDER
21.3 RETAIL SALES
21.3.1 LARGE RETAIL CHAINS
21.3.2 MANUFACTURER OWNED RETAIL CHAINS
21.3.3 OTHERS
21.4 OTHERS
22 MIDDLE EAST AND AFRICA HEARING AIDS MARKET, SWOT AND DBMR ANALYSIS
23 MIDDLE EAST AND AFRICA HEARING AIDS MARKET, COMPANY LANDSCAPE
23.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
23.2 MERGERS & ACQUISITIONS
23.3 NEW PRODUCT DEVELOPMENT & APPROVALS
23.4 EXPANSIONS
23.5 REGULATORY CHANGES
23.6 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
24 MIDDLE EAST AND AFRICA HEARING AIDS MARKET, BY REGION
MIDDLE EAST AND AFRICA HEARING AIDS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
24.1 MIDDLE EAST AND AFRICA
24.1.1 UAE
24.1.2 EGYPT
24.1.3 SOUTH AFRICA
24.1.4 SAUDI ARABIA
24.1.5 ISRAEL
24.1.6 REST OF SOUTH AMERICA
24.2 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
25 MIDDLE EAST AND AFRICA HEARING AIDS MARKET, COMPANY PROFILE
25.1 SONOVA
25.1.1 COMPANY OVERVIEW
25.1.2 REVENUE ANALYSIS
25.1.3 GEOGRAPHIC PRESENCE
25.1.4 PRODUCT PORTFOLIO
25.1.5 RECENT DEVELOPMENTS
25.2 WS AUDIOLOGY A/S
25.2.1 COMPANY OVERVIEW
25.2.2 REVENUE ANALYSIS
25.2.3 GEOGRAPHIC PRESENCE
25.2.4 PRODUCT PORTFOLIO
25.2.5 RECENT DEVELOPMENTS
25.3 DEMANT A/S
25.3.1 COMPANY OVERVIEW
25.3.2 REVENUE ANALYSIS
25.3.3 GEOGRAPHIC PRESENCE
25.3.4 PRODUCT PORTFOLIO
25.3.5 RECENT DEVELOPMENTS
25.4 COCHLEAR LTD.
25.4.1 COMPANY OVERVIEW
25.4.2 REVENUE ANALYSIS
25.4.3 GEOGRAPHIC PRESENCE
25.4.4 PRODUCT PORTFOLIO
25.4.5 RECENT DEVELOPMENTS
25.5 STARKEY LABORATORIES, INC.
25.5.1 COMPANY OVERVIEW
25.5.2 REVENUE ANALYSIS
25.5.3 GEOGRAPHIC PRESENCE
25.5.4 PRODUCT PORTFOLIO
25.5.5 RECENT DEVELOPMENTS
25.6 GN STORE NORD A/S
25.6.1 COMPANY OVERVIEW
25.6.2 REVENUE ANALYSIS
25.6.3 GEOGRAPHIC PRESENCE
25.6.4 PRODUCT PORTFOLIO
25.6.5 RECENT DEVELOPMENTS
25.7 MED-EL MEDICAL ELECTRONICS
25.7.1 COMPANY OVERVIEW
25.7.2 REVENUE ANALYSIS
25.7.3 GEOGRAPHIC PRESENCE
25.7.4 PRODUCT PORTFOLIO
25.7.5 RECENT DEVELOPMENTS
25.8 MICROSON S.A.U. (AMPLIFON)
25.8.1 COMPANY OVERVIEW
25.8.2 REVENUE ANALYSIS
25.8.3 GEOGRAPHIC PRESENCE
25.8.4 PRODUCT PORTFOLIO
25.8.5 RECENT DEVELOPMENTS
25.9 ISTOK-AUDIO GROUP
25.9.1 COMPANY OVERVIEW
25.9.2 REVENUE ANALYSIS
25.9.3 GEOGRAPHIC PRESENCE
25.9.4 PRODUCT PORTFOLIO
25.9.5 RECENT DEVELOPMENTS
25.1 GUANGDONG ENNO MEDICAL TECHNOLOGY CO., LTD.
25.10.1 COMPANY OVERVIEW
25.10.2 REVENUE ANALYSIS
25.10.3 GEOGRAPHIC PRESENCE
25.10.4 PRODUCT PORTFOLIO
25.10.5 RECENT DEVELOPMENTS
25.11 SEBOTEK HEARING SYSTEMS, LLC.
25.11.1 COMPANY OVERVIEW
25.11.2 REVENUE ANALYSIS
25.11.3 GEOGRAPHIC PRESENCE
25.11.4 PRODUCT PORTFOLIO
25.11.5 RECENT DEVELOPMENTS
25.12 ACOSOUND HEARING AIDS
25.12.1 COMPANY OVERVIEW
25.12.2 REVENUE ANALYSIS
25.12.3 GEOGRAPHIC PRESENCE
25.12.4 PRODUCT PORTFOLIO
25.12.5 RECENT DEVELOPMENTS
25.13 AUDIO SERVICE
25.13.1 COMPANY OVERVIEW
25.13.2 REVENUE ANALYSIS
25.13.3 GEOGRAPHIC PRESENCE
25.13.4 PRODUCT PORTFOLIO
25.13.5 RECENT DEVELOPMENTS
25.14 HOURI HEARING UAE
25.14.1 COMPANY OVERVIEW
25.14.2 REVENUE ANALYSIS
25.14.3 GEOGRAPHIC PRESENCE
25.14.4 PRODUCT PORTFOLIO
25.14.5 RECENT DEVELOPMENTS
25.15 AUDIFON GMBH & CO. KG (KIND-GROUP)
25.15.1 COMPANY OVERVIEW
25.15.2 REVENUE ANALYSIS
25.15.3 GEOGRAPHIC PRESENCE
25.15.4 PRODUCT PORTFOLIO
25.15.5 RECENT DEVELOPMENTS
25.16 BHM-TECH PRODUKTIONSGESELLSCHAFT MBH
25.16.1 COMPANY OVERVIEW
25.16.2 REVENUE ANALYSIS
25.16.3 GEOGRAPHIC PRESENCE
25.16.4 PRODUCT PORTFOLIO
25.16.5 RECENT DEVELOPMENTS
26 RELATED REPORTS
27 CONCLUSION
28 QUESTIONNAIRE
29 ABOUT DATA BRIDGE MARKET RESEARCH
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

